Intelligence Platform
Patents
Browse 83 pharma-relevant US patents (A61K/A61P) linked to tracked companies. Patent cliff and LOE intelligence for BD teams.
US 12398179
Nanomolar peptides and derivatives to differentially modulate ephrin receptors
granted patentUS 12365659
Non-polyamine based polyamine transport inhibitors and their use in the treatment of human
granted patentUS 12329784
Gut microbiota and treatment of cancer
granted patentUS 12319684
Agonists of the apelin receptor and methods of use thereof
granted patentUS 12290569
Methods and compositions using peptides and proteins with c-terminal elements
granted patentUS 12285392
Method for modulating metabolism
granted patentUS 12280063
Anti-retroviral therapies and reverse transcriptase inhibitors for treatment of Alzheimer'
granted patentUS 12263159
Fused ring compound having urea structure
granted patentUS 12239656
Nucleoporins as drug targets for anti-proliferative therapeutics
granted patentUS 12223643
Machine-learning system for diagnosing disorders and diseases and determining drug respons
granted patentUS 12195558
Targeted delivery system and methods of use therefor
granted patentUS 12097264
Methods and compositions for theranostic nanoparticles
granted patentUS 12071413
Azole derivatives as apelin receptor agonist
granted patentUS 12071414
Apelin receptor agonists and methods of use thereof
granted patentUS 12030896
PIKfyve inhibitors
granted patentUS 12023389
Compositions that target tumor-associated macrophages and methods of use therefor
granted patentUS 12006321
Substituted pyrazolo[1,5-a]pyrimidines as apelin receptor agonists
granted patentUS 11981752
Tumor associated monocyte/macrophage binding peptide and methods of use thereof
granted patentUS 11939367
BTLA fusion protein agonists and uses thereof
granted patentUS 11932600
Biaryl derivative
granted patentUS 11918568
Fused ring compound having urea structure
granted patentUS 11912786
Inhibitor of apoptosis protein (IAP) antagonists
granted patentUS 11905268
Anthranilic acid derivatives and their use in the treatment of human cancers
granted patentUS 11891399
Inhibitors of cancer invasion, attachment, and/or metastasis
granted